1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Global Cardiac Ablation Industry

Global Cardiac Ablation Industry

  • April 2021
  • 297 pages
  • ID: 5798096
  • Format: PDF
  • Global Industry Analysts


Table of Contents


Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

- The global market for Cardiac Ablation is projected to reach US$1.4 billion by 2025, driven by the growing burden of cardiovascular diseases worldwide. Apart from circulatory disorders caused by high blood pressure and coronary artery disease such as blockages in arteries, electrical disorders, also known as conduction disorders of the heart are also a major class of cardiovascular disease. Arrhythmias/abnormal/irregular heart rhythms can sometimes be fatal when not treated properly. Electrical impulses travel through the heart to control the heartbeat. When disruptions in the electrical flow occur it results in irregular heartbeat and rhythm. In a normal heart, electrical impulses travel down the right and left branches of the ventricles at the same speed allowing both the ventricles to contract simultaneously. When a block is encountered in the one of the ventricles, the electrical signal is rerouted through a different path result in the one ventricle contracting slower that the other resulting in arrhythmia. Arrhythmias such as Tachycardia and Bradycardia are often treated with medications, such as beta blockers and/or through surgical implantation of cardioverter defibrillator (ICD) or pacemaker.
- However, in patients unresponsive to medications and/or intolerant to its side-effects, cardiac ablation remains the standard of care for treating electrical disorders of the heart. Cardiac ablation is aimed at destroying malfunctioning tissues responsible for triggering abnormal heart rhythms. Cardiac ablation significantly improves the chances of survival of patients with atrial fibrillation. Types of arrhythmias often treated with cardiac ablation include atrial flutter ablation, pulmonary vein isolation, SVT ablation, and ventricular tachycardia ablation. Catheter ablation and surgical ablation are the two popular types of cardiac ablation techniques. Types of catheter ablation include radiofrequency ablation and cryoablation both of which includes the use of catheters to either send radiofrequency energy to scar the defective tissue or deliver extreme cold to freeze and destroy the tissue. Benefits of catheter ablation include less invasive; reduces risk of sudden cardiac arrest by over 60%; and faster recovery. Surgical ablation includes Maze and Mini maze procedures, both of which are invasive procedures. The market in the coming years is poised to immensely benefit from ongoing R&D in the use of robotic ablation of atrial fibrillation. Companies are developing robotic catheter systems that will enable more stable and precise steerability of the catheter. Robotic surgical ablation systems bring numerous benefits such as smaller incisions, eliminates catheter-tissue contact issues, higher catheter stability when compared to manual manipulation, reduced fluoroscopy exposure, ability to remotely steer the catheter, and reduction in operator error. Few of the remote navigation technologies being developed include magnetic field vectors and electromechanical. The United States and Europe represent large markets worldwide with a combined share of 74.2% of the market. China ranks as the fastest growing market with a CAGR of 16.1% over the analysis period supported by the country’s rapidly developing cardiovascular care system. Economic prosperity, globalization of unhealthy lifestyles, and rise in chronic diseases like hypertension, obesity, and diabetes mellitus have all pushed up the risk for cardiovascular disease (CVD) in the country. The Chinese government’s recent approval of the "Healthy China 2030 Plan" aims to reduce morbidity and mortality from CVDs by developing its healthcare systems and providing funding support for science and technology innovation.

- Select Competitors (Total 16 Featured) -
  • Abbott Laboratories
  • Alcon Laboratories, Inc.
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Medtronic PLC
  • Olympus Corporation

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on